321 related articles for article (PubMed ID: 25577895)
1. The effect of IL-2, IL-12 and IL15 on the function of natural killer cells in children suffering from type 1 diabetes mellitus.
Chrul S; Polakowska E; Mycko M; Fendler W; Zwiech R; Szadkowska A
Pediatr Endocrinol Diabetes Metab; 2013; 19(3):91-5. PubMed ID: 25577895
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.
Qin H; Lee IF; Panagiotopoulos C; Wang X; Chu AD; Utz PJ; Priatel JJ; Tan R
Diabetes; 2011 Mar; 60(3):857-66. PubMed ID: 21270236
[TBL] [Abstract][Full Text] [Related]
3. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus.
Guo H; Xu B; Gao L; Sun X; Qu X; Li X; Liu S; Feng J; Wang J; Tang Y; Yan G; Gao X; Jiang Y
Exp Biol Med (Maywood); 2012 May; 237(5):556-62. PubMed ID: 22547395
[TBL] [Abstract][Full Text] [Related]
4. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
7. Decreased percentage of NKG2D+NK cells in patients with incident onset of Type 1 Diabetes.
Zhang Y; Wang H; Lou X; Qu X; Gao L; Liu X; Li M; Guo H; Jiang Y
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):180-190. PubMed ID: 27862177
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
9. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
10. Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.
Nakata S; Imagawa A; Miyata Y; Yoshikawa A; Kozawa J; Okita K; Funahashi T; Nakamura S; Matsubara K; Iwahashi H; Shimomura I
Immunol Lett; 2013; 156(1-2):149-55. PubMed ID: 24177169
[TBL] [Abstract][Full Text] [Related]
11. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
[TBL] [Abstract][Full Text] [Related]
12. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12.
Mehrotra PT; Donnelly RP; Wong S; Kanegane H; Geremew A; Mostowski HS; Furuke K; Siegel JP; Bloom ET
J Immunol; 1998 Mar; 160(6):2637-44. PubMed ID: 9510161
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
[TBL] [Abstract][Full Text] [Related]
14. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
15. COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion.
Folli C; Chiappori A; Pellegrini M; Garelli V; Riccio AM; De Ferrari L; Braido F; Canonica GW
Pulm Pharmacol Ther; 2012 Oct; 25(5):371-6. PubMed ID: 22766315
[TBL] [Abstract][Full Text] [Related]
16. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
17. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells.
Hermann E; Alonso-Vega C; Berthe A; Truyens C; Flores A; Cordova M; Moretta L; Torrico F; Braud V; Carlier Y
Pediatr Res; 2006 Jul; 60(1):38-43. PubMed ID: 16690951
[TBL] [Abstract][Full Text] [Related]
18. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
20. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
